Pulsion Medical Systems SE (LTS:0NFX) Interest Expense : €0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Pulsion Medical Systems SE Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Pulsion Medical Systems SE's interest expense for the six months ended in Dec. 2023 was € 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was €0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Pulsion Medical Systems SE's Operating Income for the six months ended in Dec. 2023 was € 4.75 Mil. Pulsion Medical Systems SE's Interest Expense for the six months ended in Dec. 2023 was € 0.00 Mil. Pulsion Medical Systems SE has no long-term debt ⁽¹⁾. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Pulsion Medical Systems SE Interest Expense Historical Data

The historical data trend for Pulsion Medical Systems SE's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pulsion Medical Systems SE Interest Expense Chart

Pulsion Medical Systems SE Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.01

Pulsion Medical Systems SE Semi-Annual Data
	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Interest Expense	Get a 7-Day Free Trial															-0.01	-0.01	-	-	-

Pulsion Medical Systems SE Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 was €0.00 Mil.

Pulsion Medical Systems SE (LTS:0NFX) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Pulsion Medical Systems SE's Interest Expense for the six months ended in Dec. 2023 was €0.00 Mil. Its Operating Income for the six months ended in Dec. 2023 was €4.75 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was €0.00 Mil.

Pulsion Medical Systems SE's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Pulsion Medical Systems SE had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Pulsion Medical Systems SE has enough cash to cover all of its debt. Its financial situation is stable.

Pulsion Medical Systems SE (LTS:0NFX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pulsion Medical Systems SE (LTS:0NFX) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Hans-Riedl-Street 17, Feldkirchen, DEU, 85622

Website

http://www.pulsion.com

Pulsion Medical Systems SE operates with its business units hemodynamic monitoring which is engaged in developing, manufacturing, and sale of systems used to monitor, diagnose, and manage physical parameters of patients in intensive care unit, and perfusion imaging which is engaged in developing, manufacturing, and sale of indocyanine green and complementary devices to visualize micro perfusion. The technology developed by the company for critical care are picco, proaqt, limon technology, and eirus technology.

Pulsion Medical Systems SE (LTS:0NFX) Headlines

No Headlines